Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Comparison of the Effect of Age (< 75 Versus = 75) on the Efficacy and Safety of Dual Therapy (Dabigatran?+?Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin?+?Aspirin?+?Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial).

Comparison of the Effect of Age (< 75 Versus = 75) on the Efficacy and Safety of Dual Therapy (Dabigatran?+?Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin?+?Aspirin?+?Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). Am J Cardiol. 2020 03 01; 125(5):735-743.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.